Notes - Finance Income And Finance Costs

Astellas Pharma Inc. - Filing #7332273

Concept 2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
Notes - Finance income and finance costs
Components of finance income and finance costs
Finance income
Other
220,000,000 JPY
2,706,000,000 JPY
Finance income
11,455,000,000 JPY
8,110,000,000 JPY
Finance costs
Other
1,945,000,000 JPY
403,000,000 JPY
Finance costs
12,005,000,000 JPY
8,779,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.